Topamax (topiramate) is a brand-name drug that a doctor or healthcare professional may prescribe off-label for weight loss. The drug is not approved for this use, but it has been shown to help ...
Verywell Health on MSN8 个月
Topamax (Topiramate) for Weight Loss
Topamax (topiramate) is an anticonvulsant or a drug used to treat seizures. It is also approved to prevent migraine headaches ...
Topamax (topiramate) is a brand-name prescription drug used to prevent migraine attacks and treat epilepsy in certain people. Long-term side effects with Topamax are not common but can occur in ...
This active drug is also available as the brand-name medication Topamax. This article only describes how and when to take topiramate oral tablets. If you’d like to learn more about other forms ...
Get detailed information on Topiramate, including pronunciation, uses, dosage guidelines, indications, and instructions on how and when to take it and when to avoid it. The updated prescription ...
Other antiepileptics, such as carbamazepine (Tegretol) and topiramate (Topamax), may also be of benefit. Of these medications, only gabapentin enacarbil (Horizant) has been approved by the FDA ...
But for women with epilepsy who also suffer from migraine headaches, Topamax is usually considered the drug of choice because of its headache-relieving properties, Pack says. Like Lamictal ...
A prevalent but lesser-known diagnosisMedically reviewed by Rachel Goldman, PhD, FTOSOther specified feeding and eating ...
“I call them precision-guided missiles, because they target specific molecules and pathways compared to, say Topamax, which ...
Some of these include: Topamax, an antiseizure medication approved for use in the treatment of epilepsy Wellbutrin, an antidepressant Using prescription drugs that aren't officially approved by ...
A combination of metformin and topiramate along with a low-calorie diet was an effective, low-cost weight loss strategy in women with polycystic ovary syndrome.
Migraine is a common neurological syndrome that affects approximately 10–20% of the population. The pathophysiology of migraine is unclear. 5-hydroxytriptamine is a key mediator in the ...